We also found that AIM2 was highly methylated in patients with high-risk osteosarcoma and was expressed lower in metastatic osteosarcoma cells, which was consistent with the point that loss of AIM2 promotes cancer metastasis (40, 41). Here, AIM2 is linked to cancer.